Growth Metrics

Iridex (IRIX) Convertible Debt (2024 - 2026)

Iridex's quarterly Convertible Debt came in at $3.8 million in Q2 2026, up 3.32% year-on-year from $3.6 million in Q2 2025, and up 0.8% quarter-over-quarter from $3.7 million in Q1 2026.

Iridex has reported Convertible Debt for 3 years, with the latest figure at $3.8 million in Q2 2026.

  • For the quarter ending Q2 2026, Convertible Debt rose 3.32% year-over-year to $3.8 million; the trailing twelve-month figure through Apr 2026 stood at $3.8 million (up 3.32% YoY), and the FY2026 full-year result was $3.7 million, up 38.33% from the prior year.
  • Convertible Debt for Q2 2026 stood at $3.8 million, up from $3.7 million in the prior quarter.
  • The five-year high for Convertible Debt was $3.8 million in Q2 2026, with the low at $1.4 million in Q3 2024.
  • Average Convertible Debt over 3 years is $3.2 million, with a median of $3.7 million recorded in 2025.
  • Year-over-year, Convertible Debt jumped 156.58% in 2025 and advanced 3.32% in 2026.
  • Tracing IRIX's Convertible Debt over 3 years: stood at $2.7 million in 2024, then jumped by 37.22% to $3.7 million in 2025, then grew by 1.62% to $3.8 million in 2026.
  • The last three Convertible Debt figures came in at $3.8 million (Q2 2026), $3.7 million (Q1 2026), and $3.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Iridex 18.87 Mn 14.27 Mn 4.74 Mn

Historic Data

Download Data 🔒
DateValue
Apr 4, 2026 3.77 Mn
Jan 3, 2026 3.74 Mn
Sep 27, 2025 3.71 Mn
Jun 28, 2025 3.68 Mn
Mar 29, 2025 3.64 Mn
Dec 28, 2024 2.70 Mn
Sep 28, 2024 2.70 Mn